| 标题 |
[求助补充材料]
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:John H. Krystal; John M. Kane; Christoph U. Correll; David P. Walling; Matthew Leoni; et al 出版日期:2022-12-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)